Generation of Non-Complement-Fixing, Blocking Factors by Lysosomal Extract Treatment of Cytotoxic Anti-Tumor Antibodies

Abstract
Alloantibodies against EL-4 lymphoma and P-815 mastocytoma were raised by immunization of DBA/2 and C57BL/6 mice, respectively. Such antisera were capable of mediating complement-dependent cytotoxicity and of blocking specific killing by alloimmune lymphocytes. Treatment with lysosomal enzymes derived from the tumor decreased the ability of these alloantibodies to mediate complement-dependent cytotoxicity but left intact their blocking activity. Such degradation, if it were to occur, in vivo could contribute to enhanced tumor growth.

This publication has 0 references indexed in Scilit: